On the latest episode of "The Joy of Why," Nobel laureate Jennifer Doudna reflects on the remarkable arc of CRISPR—from her breakthrough discovery of its genome-editing potential to today's expanding frontiers. According to Quanta Magazine, Doudna explores the technology's explosive growth over the past decade: the early wins that proved CRISPR could precisely edit DNA, the unexpected hurdles researchers encountered as they scaled the approach, and the unresolved puzzles that will define gene editing's next chapter. The conversation examines both the transformative promise—treating genetic diseases at their root—and the lingering challenges: delivering CRISPR reliably into the right cells, minimizing off-target cuts, and navigating the ethical terrain of heritable changes. Doudna's reflections underscore that while CRISPR democratized genome editing, turning a bacterial defense system into a precision tool, the technology is still in adolescence. The next era of gene editing, she suggests, will be defined not by breakthrough moments, but by the patient work of turning possibility into clinical reality.

Listen to this story

Hear this and more stories in a personalized audio briefing.

Open The Chonkerton